FDA Approves New Kidney Cancer Treatment Combo

The FDA just approved a powerful new combination therapy that could help thousands of kidney cancer patients stay cancer-free after surgery.

Merck's belzutifan paired with Keytruda offers new hope for those at high risk of their cancer returning.